CytoMed Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.About GDTC
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments.
GDTC Key Statistics
Stock Snapshot
With a market cap of 12.19M, CytoMed Therapeutics(GDTC) trades at $1.04. The stock has a price-to-earnings ratio of -3.94.
As of 2026-07-12, CytoMed Therapeutics(GDTC) stock has fluctuated between $0.94 and $1.05. The current price stands at $1.04, placing the stock +10.5% above today's low and -1.0% off the high.
The CytoMed Therapeutics(GDTC)'s current trading volume is 54.59K, compared to an average daily volume of 14.89K.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $3.68 and a 52-week low of $0.68.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $3.68 and a 52-week low of $0.68.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.